323 related articles for article (PubMed ID: 26116791)
1. Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy.
Spreafico M; Berzuini A; Foglieni B; Candotti D; Raffaele L; Guarnori I; Colli A; Maldini FF; Allain JP; Prati D
J Hepatol; 2015 Nov; 63(5):1068-76. PubMed ID: 26116791
[TBL] [Abstract][Full Text] [Related]
2. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Stramer SL; Notari EP; Krysztof DE; Dodd RY
Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
[TBL] [Abstract][Full Text] [Related]
4. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
Busch MP
Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
[TBL] [Abstract][Full Text] [Related]
5. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
6. NAT for HBV and anti-HBc testing increase blood safety.
Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
[TBL] [Abstract][Full Text] [Related]
7. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
van de Laar TJ; Hogema BM; Molenaar-de Backer MW; Marijt-van der Kreek T; Zaaijer HL
Transfusion; 2021 Jul; 61(7):2116-2124. PubMed ID: 33899233
[TBL] [Abstract][Full Text] [Related]
8. High Frequency Occult Hepatitis B Virus Infection Detected in Non-Resolved Donations Suggests the Requirement of Anti-HBc Test in Blood Donors in Southern China.
Ye X; Zhao Y; Li R; Li T; Zheng X; Xiong W; Zeng J; Xu M; Chen L
Front Immunol; 2021; 12():699217. PubMed ID: 34394093
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
10. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test.
Kleinman SH; Strong DM; Tegtmeier GG; Holland PV; Gorlin JB; Cousins C; Chiacchierini RP; Pietrelli LA
Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909
[TBL] [Abstract][Full Text] [Related]
12. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P
Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631
[TBL] [Abstract][Full Text] [Related]
13. Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay.
Tsoi WC; Lelie N; Lin CK
Transfusion; 2013 Oct; 53(10 Pt 2):2477-88. PubMed ID: 23521050
[TBL] [Abstract][Full Text] [Related]
14. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
Taira R; Satake M; Momose S; Hino S; Suzuki Y; Murokawa H; Uchida S; Tadokoro K
Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection.
Kiely P; Margaritis AR; Seed CR; Yang H;
Transfusion; 2014 Aug; 54(8):2084-91. PubMed ID: 24650170
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil.
Corrêa ASM; Lamarão LM; Vieira PCM; de Castro RBH; de Almeida NCC; de Castro JAA; de Lima MSM; Palmeira MK; Meireles ALLP; Burbano RR
PLoS One; 2018; 13(12):e0208414. PubMed ID: 30566494
[TBL] [Abstract][Full Text] [Related]
18. Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion.
Panigrahi R; Biswas A; Datta S; Banerjee A; Chandra PK; Mahapatra PK; Patnaik B; Chakrabarti S; Chakravarty R
Virol J; 2010 Aug; 7():204. PubMed ID: 20799931
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection: implications in transfusion.
Allain JP
Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
[TBL] [Abstract][Full Text] [Related]
20. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
